Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

In situ modulation of oxidative stress: a novel and efficient strategy to kill cancer cells.

Verrax J, Pedrosa RC, Beck R, Dejeans N, Taper H, Calderon PB.

Curr Med Chem. 2009;16(15):1821-30. Review.

PMID:
19442148
2.

Redox-active quinones and ascorbate: an innovative cancer therapy that exploits the vulnerability of cancer cells to oxidative stress.

Verrax J, Beck R, Dejeans N, Glorieux C, Sid B, Pedrosa RC, Benites J, Vásquez D, Valderrama JA, Calderon PB.

Anticancer Agents Med Chem. 2011 Feb;11(2):213-21. Review.

PMID:
21395522
3.

Nrf2 and antioxidant defense against CYP2E1 toxicity.

Cederbaum A.

Expert Opin Drug Metab Toxicol. 2009 Oct;5(10):1223-44. doi: 10.1517/17425250903143769. Review.

PMID:
19671018
4.

[Oxidative stress in cells damage processes].

Kulbacka J, Saczko J, Chwiłkowska A.

Pol Merkur Lekarski. 2009 Jul;27(157):44-7. Review. Polish.

PMID:
19650429
5.

Targeting cancer cells by an oxidant-based therapy.

Verrax J, Taper H, Buc Calderon P.

Curr Mol Pharmacol. 2008 Jan;1(1):80-92. Review.

PMID:
20021426
6.

HIF-1alpha modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms.

Marín-Hernández A, Gallardo-Pérez JC, Ralph SJ, Rodríguez-Enríquez S, Moreno-Sánchez R.

Mini Rev Med Chem. 2009 Aug;9(9):1084-101. Review.

PMID:
19689405
7.

Antioxidant and pro-oxidant capacities of ITCs.

Valgimigli L, Iori R.

Environ Mol Mutagen. 2009 Apr;50(3):222-37. doi: 10.1002/em.20468. Review.

PMID:
19197991
8.

The controversial place of vitamin C in cancer treatment.

Verrax J, Calderon PB.

Biochem Pharmacol. 2008 Dec 15;76(12):1644-52. doi: 10.1016/j.bcp.2008.09.024. Epub 2008 Sep 30. Review.

PMID:
18938145
9.

Metabolism and cell biology of vitamin K.

Shearer MJ, Newman P.

Thromb Haemost. 2008 Oct;100(4):530-47. Review.

PMID:
18841274

Supplemental Content

Support Center